Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
INR 34.65
(-1.08%)
INR 34.65
(-1.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -7.43 Million INR | -212.59% |
| 2022 | 6.19 Million INR | 158.84% |
| 2021 | 2.39 Million INR | -93.08% |
| 2020 | 34.58 Million INR | 86.43% |
| 2019 | 18.55 Million INR | 267.06% |
| 2018 | 5.05 Million INR | -19.39% |
| 2017 | 6.26 Million INR | -62.56% |
| 2016 | 16.74 Million INR | 65.41% |
| 2015 | 10.12 Million INR | -29.55% |
| 2014 | 14.36 Million INR | 56.28% |
| 2013 | 9.19 Million INR | 141.29% |
| 2012 | 3.81 Million INR | -33.78% |
| 2011 | 5.75 Million INR | 166.23% |
| 2010 | 2.16 Million INR | 235.4% |
| 2009 | -1.59 Million INR | -119.37% |
| 2008 | -727.74 Thousand INR | -118.29% |
| 2007 | 3.97 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2 Million INR | 6.08% |
| 2023 FY | -6.97 Million INR | -212.59% |
| 2023 Q2 | 610 Thousand INR | 17.76% |
| 2023 Q4 | -2.13 Million INR | -213.54% |
| 2023 Q1 | 518 Thousand INR | -71.29% |
| 2023 Q3 | 1.88 Million INR | 208.69% |
| 2022 Q4 | 1.8 Million INR | -32.23% |
| 2022 Q2 | 465 Thousand INR | -63.15% |
| 2022 Q1 | 1.26 Million INR | 43.6% |
| 2022 FY | 6.19 Million INR | 158.84% |
| 2022 Q3 | 2.66 Million INR | 472.47% |
| 2021 Q4 | 878.81 Thousand INR | -20.32% |
| 2021 Q3 | 1.1 Million INR | 313.11% |
| 2021 Q2 | 267 Thousand INR | 85.42% |
| 2021 Q1 | 144 Thousand INR | -99.37% |
| 2021 FY | 2.39 Million INR | -93.08% |
| 2020 Q4 | 22.69 Million INR | 239.54% |
| 2020 Q3 | 6.68 Million INR | 68.45% |
| 2020 Q2 | 3.96 Million INR | 220.78% |
| 2020 Q1 | 1.23 Million INR | -80.31% |
| 2020 FY | 34.58 Million INR | 86.43% |
| 2019 Q4 | 6.28 Million INR | 52.31% |
| 2019 Q1 | 7.93 Million INR | 272.0% |
| 2019 Q3 | 4.12 Million INR | 1827.1% |
| 2019 FY | 18.55 Million INR | 267.06% |
| 2019 Q2 | 214 Thousand INR | -97.3% |
| 2018 Q1 | 895 Thousand INR | 192.48% |
| 2018 Q3 | 1.75 Million INR | 550.74% |
| 2018 Q4 | 2.13 Million INR | 21.34% |
| 2018 FY | 5.05 Million INR | -19.39% |
| 2018 Q2 | 270 Thousand INR | -69.83% |
| 2017 Q4 | 306 Thousand INR | -59.2% |
| 2017 Q2 | 537 Thousand INR | -88.52% |
| 2017 FY | 6.26 Million INR | -62.56% |
| 2017 Q1 | 4.67 Million INR | 65.57% |
| 2017 Q3 | 750 Thousand INR | 39.66% |
| 2016 Q4 | 2.82 Million INR | 7.78% |
| 2016 FY | 16.74 Million INR | 65.41% |
| 2016 Q3 | 2.62 Million INR | 452.0% |
| 2016 Q2 | 475 Thousand INR | -95.61% |
| 2016 Q1 | 10.82 Million INR | 4745.49% |
| 2015 FY | 10.12 Million INR | -29.55% |
| 2015 Q3 | 1.33 Million INR | -21.73% |
| 2015 Q4 | -233 Thousand INR | -117.48% |
| 2015 Q1 | 7.32 Million INR | 194.49% |
| 2015 Q2 | 1.7 Million INR | -76.74% |
| 2014 Q3 | 6.05 Million INR | 60.08% |
| 2014 Q1 | 2.01 Million INR | 36.9% |
| 2014 FY | 14.36 Million INR | 56.28% |
| 2014 Q2 | 3.78 Million INR | 87.93% |
| 2014 Q4 | 2.48 Million INR | -58.97% |
| 2013 Q3 | 3.46 Million INR | 884.09% |
| 2013 Q4 | 1.47 Million INR | -57.53% |
| 2013 FY | 9.19 Million INR | 141.29% |
| 2013 Q1 | 3.9 Million INR | 1522.54% |
| 2013 Q2 | 352 Thousand INR | -90.99% |
| 2012 Q4 | 240.85 Thousand INR | -84.7% |
| 2012 Q1 | 1.08 Million INR | -39.05% |
| 2012 FY | 3.81 Million INR | -33.78% |
| 2012 Q3 | 1.57 Million INR | 72.4% |
| 2012 Q2 | 913 Thousand INR | -15.7% |
| 2011 Q4 | 1.77 Million INR | -6.24% |
| 2011 Q3 | 1.89 Million INR | 0.0% |
| 2011 FY | 5.75 Million INR | 166.23% |
| 2010 FY | 2.16 Million INR | 235.4% |
| 2009 FY | -1.59 Million INR | -119.37% |
| 2008 Q4 | 668 Thousand INR | 0.0% |
| 2008 FY | -727.74 Thousand INR | -118.29% |
| 2007 FY | 3.97 Million INR | 0.0% |
| 2007 Q4 | 2.26 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 3.14 Million INR | 336.702% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 100.62% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 106.651% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 106.698% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 103.579% |
| Sunil Healthcare Limited | 247.86 Million INR | 102.999% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | 140.436% |
| MedPlus Health Services Limited | 12.33 Billion INR | 100.06% |
| Zenith Healthcare Limited | 46.17 Million INR | 116.098% |
| Patidar Buildcon Limited | -26 Thousand INR | -28488.462% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 103.559% |
| Roopa Industries Limited | 72.95 Million INR | 110.189% |
| Smruthi Organics Limited | 324.76 Million INR | 102.289% |
| Trident Lifeline Limited | 119.08 Million INR | 106.242% |
| Bacil Pharma Limited | -19.95 Thousand INR | -37158.145% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 89.792% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 105.256% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 94.932% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 102.141% |
| PANJON LTD. | 33.77 Million INR | 122.005% |
| Tyche Industries Limited | 290.84 Million INR | 102.556% |
| Trimurthi Limited | 1.95 Million INR | 480.984% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 58.265% |
| Anuh Pharma Limited | 1.6 Billion INR | 100.464% |
| Crestchem Limited | 51.53 Million INR | 114.422% |
| Zenlabs Ethica Limited | 147.75 Million INR | 105.031% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 101.675% |
| ANG Lifesciences India Limited | 232.73 Million INR | 103.194% |
| Parmax Pharma Limited | 99.31 Million INR | 107.484% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 101.026% |
| Deccan Health Care Limited | 221.57 Million INR | 103.355% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 102.474% |
| Norris Medicines Limited | 29.36 Million INR | 125.315% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 102.055% |
| Veerhealth Care Limited | 49.57 Million INR | 114.994% |
| Makers Laboratories Limited | 308.54 Million INR | 102.409% |
| Lactose (India) Limited | 230.3 Million INR | 103.227% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 92.552% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 101.036% |
| Mercury Laboratories Limited | 279.39 Million INR | 102.66% |
| Gennex Laboratories Limited | 276.99 Million INR | 102.683% |
| PRAVEG LIMITED | 266.99 Million INR | 102.784% |
| Denis Chem Lab Limited | 596.24 Million INR | 101.247% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 100.517% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 100.671% |
| Colinz Laboratories Limited | 16.35 Million INR | 145.448% |
| Godavari Drugs Limited | 359.01 Million INR | 102.07% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -1730.788% |
| Zenotech Laboratories Limited | 337.19 Million INR | 102.204% |
| Panchsheel Organics Limited | 356.44 Million INR | 102.085% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 101.103% |
| Vivanza Biosciences Limited | 19.38 Million INR | 138.34% |
| Phaarmasia Limited | 38.89 Million INR | 119.113% |
| Bharat Parenterals Limited | 989.46 Million INR | 100.751% |
| Medi-Caps Limited | 68.09 Million INR | 110.916% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 102.243% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 100.58% |
| BDH Industries Limited | 175.55 Million INR | 104.234% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | 174.182% |
| Coral Laboratories Limited | 332.39 Million INR | 102.236% |
| Concord Drugs Limited | 116.7 Million INR | 106.369% |
| Beryl Drugs Limited | 108.5 Million INR | 106.851% |
| Evoq Remedies Limited | 47.43 Million INR | 115.67% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 103.317% |
| Transchem Limited | -8.96 Million INR | 17.098% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | 119.088% |
| Parnax Lab Limited | 552.1 Million INR | 101.346% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 111.26% |
| Kerala Ayurveda Limited | 447.69 Million INR | 101.66% |
| Cian Healthcare Limited | 113.16 Million INR | 106.568% |
| Trinity League India Limited | 1.23 Million INR | 703.328% |
| Syschem (India) Limited | 569.04 Million INR | 101.306% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 81.743% |
| Natural Capsules Limited | 557.1 Million INR | 101.334% |
| Auro Laboratories Limited | 249.39 Million INR | 102.98% |